Navigation Links
Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Date:9/20/2012

on under the Securities Act and applicable state securities laws. The Notes and the Concurrent Notes will be offered in the United States only to qualified institutional buyers pursuant to Rule 144A under the Securities Act and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act. Neither the Notes nor the Concurrent Notes have been nor will be qualified for sale to the public by prospectus under applicable Canadian securities laws and, accordingly, any offer and sale of the securities in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.

Caution Regarding Forward-Looking Information and "Safe Harbor" Statement
This press release may contain forward-looking statements, including, but not limited to, the expected closing of the offerings, the expected use of proceeds from the offerings and the guarantees that will be provided in relation to the Notes and the Concurrent Notes. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and v
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
2. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
3. Valeant Pharmaceuticals To Syndicate Incremental Loans
4. Valeant Pharmaceuticals Announces Management Change
5. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
6. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
7. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
8. Valeant Pharmaceuticals To Host Investor Day
9. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
10. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
11. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  InnoPharma, Inc. today ... 10mg/vial (the generic equivalent of Zyprexa® injection), in Canada.  ... and disturbed behaviors in patients with schizophrenia or bipolar ... generic injectable drug, InnoPharma has entered into an agreement ... Canada will make, use, sell, market and distribute ...
(Date:7/30/2014)... Cynosure, Inc. (NASDAQ: CYNO ... non-invasive and minimally invasive applications, today announced that the Board ... and Chief Financial Officer Timothy W. Baker to ... will continue to serve as CFO and will take the ... Chairman and Chief Executive Officer. "Tim has ...
(Date:7/30/2014)... SAN DIEGO , July 30, 2014 /PRNewswire/ ... ) announced today that an article based on post-hoc analyses ... "Early Weight Loss While on Lorcaserin, Diet, and Exercise as ... in the online issue of Obesity , the official ... these analyses was to identify whether there is an early ...
Breaking Medicine Technology:InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7
... Mass., Nov. 17 Decision Resources, one of the world,s ... finds that, driven by the continued dominance of opioids that ... cancer pain drug market will increase from $2.3 billion in ... France, Germany, Italy, Spain, the United Kingdom and Japan. , ...
... , DURHAM, N.C., Nov. 17 Oxygen ... the company has begun shipping Dermacyte(TM) Oxygen Concentrate Gel ... The shipments, which are going out today, cover orders ... milestone event for our company - actually shipping a ...
Cached Medicine Technology:The Cancer Pain Drug Market, Driven by the Continued Dominance of Opioids, Will Increase From $2.3 Billion in 2008 to $3.7 Billion in 2018 2Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers 2
(Date:7/30/2014)... Volunteers from the Church of Scientology of ... summer with massive distribution of Truth About Drugs ... volunteers on Strøget, the famous Copenhagen walking street. ... and its ambiance, some quarter of a million people ... , These activities are part of a coordinating ...
(Date:7/30/2014)... Hawley, Pennsylvania (PRWEB) July 30, 2014 ... and have contributed over $8,500 to ensure its protection. ... Resort, presents a check to the Delaware Highlands Conservancy ... Partnership program. The small $2-per-stay donations add up fast, ... future of the Upper Delaware River Region. , The ...
(Date:7/30/2014)... NJ. July 30, 2014. A new network of 25 ... Stroke Trials Network (NIH StrokeNet) is working to ... U.S. Despite advances of the last two decades, ... stroke causes death or disability for 795,000 Americans. The ... of the population. , To accelerate the pace ...
(Date:7/30/2014)... July 30, 2014 LTC Consumer, an independent, ... term care insurance, features an Instant Quote tool on its ... co-founder of LTC Consumer. Quotes are free and unlimited. , ... in only seven areas – including age, gender, and state ... within seconds (you don’t need to enter any contact information ...
(Date:7/30/2014)... NY (PRWEB) July 30, 2014 The ... school, is pleased to announce that Arianna Huffington has joined ... curriculum of the Health Coach Training Program . , ... Huffington Post, a world-renowned news and blogging site that won ... the author of fourteen books and was included on the ...
Breaking Medicine News(10 mins):Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 2Health News:Arianna Huffington Joins Integrative Nutrition as a Guest Speaker 3
... calories boost lifespan , THURSDAY, July 9 (HealthDay News) -- ... the aging process in monkeys could be the best proof ... , "The big question in aging research is, ,Will caloric ... Richard Weindruch, senior author of a paper appearing in the ...
... ... , ... 9, 2009 -- MarketArt is proud to announce that it has been selected by AAMSE ... Society Executives (AAMSE) 2009 Annual Conference. , , , , ,MarketArt will provide its You ...
... China, July 9 /PRNewswire-FirstCall/ - Hard to Treat ... and as previously released on June 24, 2009, ... its ownership rights to certain intellectual property, which ... HTDS. 100% of the ownership rights are expected ...
... the Scripps Research Institute have developed an innovative technique to ... to take the place of the antibodies used in many ... Elizabeth W. Gilloon Professor and professor of chemistry, along with ... at the Scripps Research Institute and winner of the 2001 ...
... LOS ANGELES (July 8, 2009) Carole Wagner Vallianos, ... Institute at Harbor-UCLA Medical Center (LA BioMed), will be inaugurated ... Annual Meeting in Chicago on July 30. Founded in ... organization of judges, lawyers and other members of the public ...
... United States Senate Committee on Small Business and ... Olympia J. Snowe, R-Maine, today convened a roundtable ... to small businesses. Participants at the roundtable, entitled ... Perspective of Small Businesses," included U.S. Sen. Ron ...
Cached Medicine News:Health News:Lighter Meals May Bring Longer Life 2Health News:Lighter Meals May Bring Longer Life 3Health News:MarketArt to Enhance Attendee Experience at AAMSE Annual Conference 2Health News:MarketArt to Enhance Attendee Experience at AAMSE Annual Conference 3Health News:Hard To Treat Diseases (HTDS.PK) Reasserting Multi Million Dollar IP Ownership Rights 2Health News:Hard To Treat Diseases (HTDS.PK) Reasserting Multi Million Dollar IP Ownership Rights 3Health News:Caltech chemists say antibody surrogates are just a 'click' away 2Health News:Caltech chemists say antibody surrogates are just a 'click' away 3Health News:LA BioMed President and CEO will be named president of the American Judicature Society 2Health News:Landrieu, Snowe Convene Roundtable on Healthcare for Small Businesses 2Health News:Landrieu, Snowe Convene Roundtable on Healthcare for Small Businesses 3
Subretinal Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Silicone Oil Cannula; 16g (1.40) x 8mm....
Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 5mm, 30g (0.30)....
...
Medicine Products: